AIb2.io - AI Research Decoded

Before: drug-resistant tuberculosis treatment could drag on like a bedtime routine designed by a tiny chaos goblin. After: researchers sequenced the bug, let an AI recommend the drugs, and shaved months off treatment for many patients.

Fix the endpoint-adjudication bottleneck, and you unblock faster trial analysis, which enables cheaper studies, which might let useful heart drugs spend less time rotting in paperwork purgatory. That is the PR this paper opens: can an AI reviewer handle major adverse cardiovascular events, or MACE,...

At 9:12 a.m., your single-cell pipeline staggers into work carrying two cursed backpacks - one full of gene expression counts, the other full of chromatin accessibility peaks - and both are leaking mysterious biological confetti onto the floor. By lunch, it has to decide which cells are which, why...

Artificial intelligence has developed a mild habit of demanding absurd amounts of data movement, electricity, and hardware therapy. The usual arrangement is almost comically inefficient: a sensor notices something, memory stores it somewhere else, a processor wanders over to fetch it, and the whole...

When Apollo 11 touched down, nobody at mission control said, "Close enough, the Moon is basically around here." Precision mattered. That is also the vibe of this new glioblastoma paper, except instead of a lunar module, the researchers are trying to land treatment on the sneaky microscopic cells...

The new Cancer Discovery paper by Winslow and colleagues reads less like a victory lap and more like a whiteboard after a very intense meeting where nobody was allowed to pretend the easy problems were solved [1]. If I am reading this right, the authors are saying: yes, targeted therapies got...

Two types of people: those who already spend time thinking about what happens to a wind turbine blade after 20 years of heroic spinning, and those about to find out that the answer is, historically, "something mildly embarrassing for a clean-energy industry."

A cancer drug can survive years of chemistry, tissue slides, animal studies, and enough meetings to qualify as psychological warfare, then still fall apart because the right clue was sitting in the wrong database. That failure mode is the backdrop for Richard Goodwin and colleagues’ new Cancer...

Every drug you've ever taken works by hitting one of just 716 molecular targets - out of roughly 20,000 possible protein-coding genes in your body.

Most aging research has been surfing one wave at a time. Maybe you get blood biomarkers. Maybe gene expression. Maybe metabolomics. Maybe some fancy facial imaging that makes you feel like your cheekbones just joined a clinical trial. The problem is that real human data shows up like a chaotic...

16. That is how many direct service points Sony's table-tennis robot Ace scored against elite human players in the Nature study, which is the sort of statistic that makes you put your coffee down and stare at the wall for a second. Not because a robot won a few ping-pong points. Because table...

What if you could watch a battery crack, swell, plate metal where it absolutely should not, and slowly ruin its own future while it is still doing the polite public performance of "charging normally"? That sounds like sci-fi lab goggles nonsense, but it is basically the point of this review by Das,...

Back in 1977, scientists realized genes were not the neat, uninterrupted instruction manuals everyone hoped for. They came in pieces. By 1980, it was clear cells could remix those pieces through alternative splicing, making multiple RNA messages from one gene [1-4]. Since then, researchers have...

A missed heart diagnosis is not an abstract computer science problem. It is a parent who gets more winded every week and keeps blaming "bad sleep," a patient who learns too late that heart failure had been creeping in like a thief in gym socks, and families making life-changing decisions on a clock...

How can a CT scan catch too many lung nodules when it still risks missing the ones that matter? That is the deeply rude little paradox sitting at the center of modern chest imaging: scanners are excellent at finding suspicious specks, but sorting the harmless dots from the genuinely scary ones is...

Back in 2010, Gregory Lip and colleagues published the CHA₂DS₂-VASc score (Lip et al., Chest, 2010), and cardiologists worldwide collectively said, "Good enough." A simple points-based system - add one for hypertension, two for age over 75, sprinkle in some diabetes - and you'd get a stroke risk...

Yesterday, "organic electronics" sounded like the slow, bendy cousin who gets invited to the hardware party but never touches the aux cord. Today, it just clocked 18.5 GHz and walked straight into microwave territory wearing polymer pants.

Perovskite solar cells already have a pretty absurd résumé. Their lab efficiency climbed from 3.8% in 2009 to around 27% for single-junction devices, which is the kind of glow-up that would make every other energy technology roll its eyes and mutter, "must be nice" (NREL; EES Solar review,...

The last time your phone glowed in your face while you doomscrolled at 1 a.m., you were already hanging out with organic electronics. Quiet little carbon-based performers in displays, solar cells, and transistors, all doing their nightly mating dance with light and charge while you pretended one...

Before this paper, head CT AI mostly looked like a smart specialist with a tiny toolbox; after it, the pitch became much bigger - train one 3D foundation model on 361,663 unlabeled head CT scans, then adapt it to a whole lineup of brain diseases without begging humans to annotate every last pixel...